Trajan Group Holdings Limited (ASX:TRJ)
0.8000
-0.0050 (-0.62%)
Oct 24, 2025, 4:10 PM AEST
Trajan Group Holdings Revenue
In the fiscal year ending June 30, 2025, Trajan Group Holdings had annual revenue of 166.46M AUD with 7.38% growth. Trajan Group Holdings had revenue of 85.46M in the half year ending June 30, 2025, with 4.10% growth.
Revenue
166.46M
Revenue Growth
+7.38%
P/S Ratio
0.73
Revenue / Employee
256.10K
Employees
650
Market Cap
122.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 166.46M | 11.44M | 7.38% |
| Jun 30, 2024 | 155.02M | -7.13M | -4.40% |
| Jun 30, 2023 | 162.15M | 54.58M | 50.74% |
| Jun 30, 2022 | 107.57M | 31.01M | 40.49% |
| Jun 30, 2021 | 76.57M | 4.72M | 6.56% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |